Format

Send to

Choose Destination
See comment in PubMed Commons below
Iran J Pediatr. 2010 Dec;20(4):487-90.

Successful treatment of fungal osteomyelitis with voriconazole in a patient with chronic granulomatous disease.

Author information

  • 1Department of Pediatrics, Tehran University of Medical Sciences, Tehran, IR Iran ; Children's Medical Center, Pediatrics Center of Excellence, Tehran University of Medical Sciences, Tehran, IR Iran.

Abstract

BACKGROUND:

Chronic granulomatous disease (CGD) is an immunodeficiency affecting phagocytic leukocytes. Defective respiratory burst mechanism renders the affected patients to be susceptible to catalase positive microorganisms. With the great successes in antibacterial prophylaxis and therapy, fungal infections are a persistent problem. Invasive aspergillosis is the most important cause of mortality in CGD.

CASE PRESENTATION:

We describe a nine year-old boy with CGD who presented with aspergillus induced skull osteomyelitis. He was successfully treated with voriconazole after initial failure of amphotericin B therapy.

CONCLUSION:

Currently, newer triazoles are recommended as initial therapy for invasive aspergillosis in immunodeficiency states such as CGD.

KEYWORDS:

Fungal Infections; Granulomatous disease; Invasive Pulmonary Aspergillosis; Osteomyelitis; Voriconazole

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk